Frederic H. Moll M.D. is a prominent figure in surgical robotics and venture investment, widely recognized as a cofounder of Intuitive Surgical and key leader behind the da Vinci system. His career reflects a blend of clinical expertise and entrepreneurial impact that has shaped the medical device landscape.
As an active investor and advisor, Moll continues to influence innovation pipelines, market expansion, and strategic decisions that affect company valuations and long term growth. Understanding his financial footprint requires looking at salary, equity, investments, and ongoing board roles rather than a single static number.
| Aspect | Details | Impact on Net Worth | Notes |
|---|---|---|---|
| Primary Role | Co-founder, early leader at Intuitive Surgical | Major equity creation | Instrumental in building the da Vinci platform |
| Current Activities | Venture partner, board memberships, advisory roles | Ongoing compensation and carried interest | Exposure to multiple high growth life sciences companies |
| Estimated Range | Not publicly disclosed; informed estimates in hundreds of millions | Highly variable with market and equity performance | Net worth tied to private holdings and portfolio exits |
| Liquidity Factors | Share sales, dividends, secondary transactions, IPOs | Cash infusions increase spendable net worth | Partial liquidity events can reshape balance sheet |
Early Career and Intuitive Surgical Foundation
Moll trained in surgery and specialized in minimally invasive techniques, which set the stage for his move into robotics. His work at Intuitive Surgical positioned him at the center of a breakthrough product that defined a new surgical paradigm. Equity grants and salary structures from this period laid the foundation for his long term wealth.
Venture Involvement and Portfolio Strategy
Life Sciences Focus
After leaving day to day operations at Intuitive Surgical, Moll directed capital into early stage ventures, often prioritizing platforms that combined hardware, software, and data. This approach diversified his exposure beyond a single company.
Board and Advisory Roles
By serving on boards and advising, Moll gained ongoing compensation, stock options, and access to insider information that can materially affect the valuation of his holdings over time.
Market Conditions and Equity Valuation
Private market valuations, public stock performance, and macroeconomic trends influence the paper value of his holdings. Liquidity events such as IPOs and secondary sales translate paper gains into spendable wealth.
Industry Recognition and Influence
Moll is frequently cited in discussions around robotic surgery, digital health transformation, and investor due diligence. His reputation can open partnerships, accelerate fundraising, and affect strategic option grants or advisory compensation.
FAQ
How reliable are net worth estimates for Frederic H. Moll M.D. given the private nature of his holdings?
Most published figures are speculative, relying on public company equity rules, secondary market data, and informed industry assumptions rather than audited statements, so they should be treated as ranges.
What portion of his net worth typically comes from Intuitive Surgical equity vesting over time?
While he no longer works full time at Intuitive Surgical, historical grants and ongoing vesting schedules can still contribute a significant share of overall compensation and wealth growth.
How do board fees and carried interest compare to equity gains in shaping his current net worth?
Board fees and carried income provide recurring cash flow, whereas equity appreciation from life sciences startups can deliver outsized but less predictable returns that drive long term net worth.
What risks should investors consider when evaluating companies associated with Frederic H. Moll M.D. as an advisor or investor?
Concentration in private markets, regulatory exposure in medical devices, and variable exit timing can create volatility, making portfolio diversification and careful due diligence essential.
Key Takeaways on Net Worth and Career Strategy
- Core wealth derives from early equity in a high growth robotic surgery platform.
- Ongoing board roles and venture investments diversify income and exposure.
- Market cycles and liquidity events cause large swings in estimated net worth.
- Reputation and network effects enhance future earning and investing opportunities.
- Transparency is limited, so public estimates should be interpreted as informed ranges.
